pyrroles has been researched along with Mastocytosis, Systemic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 14 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Below, S; Michaelis, LC | 1 |
| Akin, C; Boral, AL; Green, T; Li, X; Lin, HM; Mar, B; Mcdonald, J; Padilla, B; Shields, AL; Siebenhaar, F; Taylor, F | 1 |
| Bose, P; DeAngelo, DJ; Deininger, MW; Drummond, MW; Evans, EK; George, TI; Gotlib, J; Hexner, EO; Horny, HP; Lin, HM; Mar, BG; Quiery, AT; Radia, DH; Robinson, WA; Schmidt-Kittler, O; Tugnait, M; Verstovsek, S; Winton, EF | 1 |
| Alvarez-Twose, I; Bose, P; DeAngelo, DJ; Deininger, MW; Dybedal, I; George, TI; Gotlib, J; Heaney, ML; Hermine, O; Hexner, EO; Hicks, LK; Lin, HM; Mar, BG; Mesa, R; Mital, A; Oh, ST; Panse, J; Pettit, KM; Platzbecker, U; Radia, DH; Reiter, A; Sen, J; Span, L; Vannucchi, AM | 1 |
| Iannazzo, S; Pilkington, H; Roskell, N; Smith, S | 1 |
| Alvarez-Twose, I; DeAngelo, DJ; Deininger, MW; Dimitrijević, S; Dybedal, I; Ehlert, K; Gotlib, J; Hermine, O; Lin, HM; Panse, J; Pettit, KM; Platzbecker, U; Radia, DH; Reiter, A; Rylova, SN; Schwaab, J; Vannucchi, AM | 1 |
| Álvarez-Twose, I; Bobbili, PJ; Chin, A; DeAngelo, DJ; Dimitrijevic, S; Duh, MS; Galinsky, IA; Gotlib, J; Louie-Gao, M; Lübke, J; Norregaard, C; Perkins, C; Radia, DH; Reiter, A; Schwaab, J; Sendhil, SR; Sperr, WR; Sriskandarajah, P; Sullivan, E; Valent, P; Wang, A | 1 |
| Cavazos, K; Eswaran, S; Idilman, I; Idilman, R; Keklik Karadag, F; Maidlow, C; Miller, I; Reau, N; Shammo, J; Ustun, C | 1 |
| DeAngelo, DJ; Gotlib, J; Reiter, A | 1 |
| Hus, M; Juda, A; Kokoć, A; Krupski, W; Szudy-Szczyrek, A; Szumiło, J | 1 |
| George, TI; Gotlib, J; Reiter, A | 1 |
| Bochner, BS; Kuang, FL; Kudlaty, E; Perez, M; Stein, BL | 1 |
| Gotlib, J; Shomali, W | 1 |
| Bose, P; Verstovsek, S | 1 |
4 review(s) available for pyrroles and Mastocytosis, Systemic
| Article | Year |
|---|---|
Avapritinib in the Treatment of Systemic Mastocytosis: an Update.
Topics: Animals; Antineoplastic Agents; Disease Management; Humans; Mastocytosis, Systemic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrroles; Triazines | 2021 |
Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis.
Topics: Humans; Mastocytosis, Systemic; Pyrazoles; Pyrroles; Staurosporine; Triazines | 2022 |
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis.
Topics: Animals; Chromosome Aberrations; Hematopoietic Stem Cell Transplantation; Humans; Mastocytosis, Systemic; Mutation; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Staurosporine; Triazines | 2020 |
Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors.
Topics: Cell Proliferation; Enzyme Inhibitors; Female; Humans; Mast Cells; Mastocytosis, Systemic; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Staurosporine; Triazines | 2021 |
3 trial(s) available for pyrroles and Mastocytosis, Systemic
| Article | Year |
|---|---|
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study.
Topics: Female; Humans; Male; Mastocytosis, Systemic; Middle Aged; Psychometrics; Pyrazoles; Pyrroles; Quality of Life; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; Symptom Assessment; Triazines | 2021 |
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Mastocytosis, Systemic; Middle Aged; Pyrazoles; Pyrroles; Triazines | 2021 |
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis.
Topics: Adult; Humans; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles | 2022 |
7 other study(ies) available for pyrroles and Mastocytosis, Systemic
| Article | Year |
|---|---|
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials, Phase II as Topic; Female; Humans; Male; Mastocytosis, Systemic; Middle Aged; Pyrazoles; Pyrroles; Triazines | 2021 |
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
Topics: Humans; Mastocytosis, Systemic; Pyrazoles; Pyrroles; Retrospective Studies; Triazines; Tryptases | 2022 |
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis.
Topics: Humans; Liver Cirrhosis; Mastocytosis, Systemic; Pyrazoles; Pyrroles | 2022 |
Avapritinib for advanced systemic mastocytosis.
Topics: Humans; Mastocytosis; Mastocytosis, Systemic; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Triazines | 2022 |
Efficacy of avapritinib in refractory aggressive systemic mastocytosis: a single-patient case.
Topics: Humans; Mastocytosis, Systemic; Pyrazoles; Pyrroles; Triazines | 2023 |
Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib.
Topics: Anaphylaxis; Hematologic Neoplasms; Humans; Mast Cells; Mastocytosis; Mastocytosis, Systemic; Pyrazoles; Pyrroles; Triazines; Tryptases | 2021 |
Avapritinib for Systemic Mastocytosis.
Topics: Humans; Mast Cells; Mastocytosis; Mastocytosis, Systemic; Mutation; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Triazines | 2021 |